亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

岳陽市嘉誠生物科技有限公司銷售部  

高效氯氟氰菊酯,匹可硫酸鈉,溴蟲睛,3,4,5一三甲氧基肉桂酸,2,4一二羥基苯甲酸,三乙脂,烯丙基硫脲

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:熊先生
  • 電話:0730-8705981
  • 郵件:gcns08@ycgmp.com
  • 傳真:0730-8705981
  • QQ:2355779402
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > ***異丙嗪
***異丙嗪
單價 面議對比
詢價 暫無
發貨 湖南岳陽市付款后3天內
品牌 南箭
過期 長期有效
更新 2019-06-27 09:08
 
詳細信息
 ***異丙嗪
中文同義詞:10-(2-二甲基氨基-1-丙基)吩噻嗪***;N,N,alpha-三甲基-10H-吩噻嗪-10-乙胺***;***異丙嗪;***普魯米嗪;非那根;普魯米近;氫氯化異丙嗪;異丙嗪***
英文名稱:Promethazine hydrochloride
英文同義詞:10-(2-dimethylamino-1-propyl)phenothiazine hydrochloride;PROMETHAZINE HCL;PROMETHAZINE HYDROCHLORIDE;PHENERGAN;10-(2-(dimethylamino)propyl)phenothiazinemonohydrochloride;10-(2-(dimethylamino)propyl)-phenothiazinmonohydrochloride;10-(2-dimethylaminopropyl)phenothiazinehydrochloride;10-(3-dimethylaminoisopropyl)phenothiazinehydrochloride
CAS號: 58-33-3
分子式: C17H21ClN2S
分子量: 320.88
 
 
用途:適用于各種過敏性疾病和孕期嘔吐。
能競爭性阻斷組肢 Hl受體而產生抗組胺作用,能對抗組胺所致之毛細血管擴張,降低其通透性,緩解支氣管平滑肌收縮所致的喘息,較***苯海拉明作用強而持久。
©2025 岳陽市嘉誠生物科技有限公司銷售部 版權所有   技術支持:化工網   訪問量:12074  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |